Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications

Placenta

Volumn 34, Issue 1, 2013, Pages 57-61

  Kim, M J ^a   Kim, S Y ^a   Park, S Y ^a   Ahn, H K ^b   Chung, J H ^b   Ryu, H M ^a,b  

^a Cheil General Hospital   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

Author keywords

Fetal derived hypermethylated RASSF1A sequence; Intrauterine growth restriction; Maternal plasma; Placental dysfunction; Placental previa; Preeclampsia

Indexed keywords

BETA ACTIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ADULT; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE SEQUENCE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PLACENTA DISORDER; PLACENTA PREVIA; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; FETAL GROWTH RETARDATION; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; OSMOLAR CONCENTRATION; PLACENTA; PLACENTA DISEASES; PLACENTA PREVIA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; TUMOR SUPPRESSOR PROTEINS;

EID: 84872017889     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2012.11.001     Document Type: Article

References (31)

1. S.Y. Kim, J.H. Lim, S.Y. Park, M.Y. Kim, J.S. Choi, and H.M. Ryu Non-invasive prenatal determination of fetal gender using QF-PCR analysis of cell-free fetal DNA in maternal plasma Clin Chim Acta 413 2012 600 604
2. O. Geifman-Holtzman, C.A. Grotegut, and J.P. Gaughan Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood-a meta-analysis Am J Obstet Gynecol 195 2006 1163 1173
3. Y.M. Lo, F.M. Lun, K.C. Chan, N.B. Tsui, K.C. Chong, and R.W. Chiu Digital PCR for the molecular detection of fetal chromosomal aneuploidy Proc Natl Acad Sci U S A 104 2007 13116 13121
4. Y. Li, E. Di Naro, A. Vitucci, B. Zimmermann, W. Holzgreve, and S. Hahn Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma J Am Med Assoc 293 2005 843 849
5. T.N. Leung, J. Zhang, T.K. Lau, L.Y. Chan, and Y.M. Lo Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia Clin Chem 47 2001 137 139
6. S. Illanes, M. Parra, R. Serra, K. Pino, H. Figueroa-Diesel, and P.W. Soothill Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction Prenat Diagn 29 2009 1118 1122
7. S.S. Chim, Y.K. Tong, R.W. Chiu, T.K. Lau, T.N. Leung, and Y.M. Lo Detection of the placental epigenetic signature of the maspin gene in maternal plasma Proc Natl Acad Sci U S A 102 2005 14753 14758
8. K.C. Chan, C. Ding, A. Gerovassili, S.W. Yeung, R.W. Chiu, and Y.M. Lo Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis Clin Chem 52 2006 2211 2218
9. J.M. Roberts, and D.W. Cooper Pathogenesis and genetics of pre-eclampsia Lancet 357 2001 53 56
10. C.W. Redman, and I.L. Sargent Placental debris, oxidative stress and pre-eclampsia Placenta 21 2000 597 602
11. R.J. Levine, C. Qian, E.S. Leshane, K.F. Yu, L.J. England, and D.W. Bianchi Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia Am J Obstet Gynecol 190 2004 707 713
12. A.M. Borzychowski, I.L. Sargent, and C.W. Redman Inflammation and pre-eclampsia Semin Fetal Neonatal Med 11 2006 309 316
13. Y.M. Lo, T.N. Leung, M.S. Tein, I.L. Sargent, J. Zhang, and C.W. Redman Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia Clin Chem 45 1999 184 188
14. X.Y. Zhong, H. Laivuori, J.C. Livingston, O. Ylikorkala, B.M. Sibai, and S. Hahn Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia Am J Obstet Gynecol 184 2001 414 419
15. D.W. Swinkels, J.B. de Kok, J.C. Hendriks, E. Wiegerinck, P.L. Zusterzeel, and E.A. Steegers Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum Clin Chem 48 2002 650 653
16. A. Farina, A. Sekizawa, Y. Sugito, M. Iwasaki, M. Jimbo, and T. Okai Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients Prenat Diagn 24 2004 83 86
17. A. Crowley, C. Martin, P. Fitzpatrick, O. Sheils, C. O'Herlihy, and B.M. Byrne Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia Prenat Diagn 27 2007 174 179
18. M.S. Alberry, D.G. Maddocks, M.A. Hadi, H. Metawi, L.P. Hunt, and P.W. Soothill Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction Am J Obstet Gynecol 200 2009 98 e1-6
19. A.M. Cotter, C.M. Martin, J.J. O'leary, and S.F. Daly Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia Am J Obstet Gynecol 191 2004 515 520
20. D.W. Tsui, K.C. Chan, S.S. Chim, L.W. Chan, T.Y. Leung, and R.W. Chiu Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia Prenat Diagn 27 2007 1212 1218
21. F. Zhao, J. Wang, R. Liu, J. Yang, K. Cui, and X. Wang Quantification and application of the placental epigenetic signature of the RASSF1A gene in maternal plasma Prenat Diagn 30 2010 778 782
22. E. DiFederico, O. Genbacev, and S.J. Fisher Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall Am J Pathol 155 1999 293 301
23. A.D. Allaire, K.A. Ballenger, S.R. Wells, M.J. McMahon, and B.A. Lessey Placental apoptosis in preeclampsia Obstet Gynecol 96 2000 271 276
24. C.T. Erel, B. Dane, Z. Calay, S. Kaleli, and K. Aydinli Apoptosis in the placenta of pregnancies complicated with IUGR Int J Gynaecol Obstet 73 2001 229 235
25. N. Ishihara, H. Matsuo, H. Murakoshi, J.B. Laoag-Fernandez, T. Samoto, and T. Maruo Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation Am J Obstet Gynecol 186 2002 158 166
26. Y. Oyelese, and J.C. Smulian Placenta previa, placenta accreta, and vasa previa Obstet Gynecol 107 2006 927 941
27. P. Tantbirojn, C.P. Crum, and M.M. Parast Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast Placenta 29 2008 639 645
28. H.S. Brar, A.L. Medearis, G.R. DeVore, and L.D. Platt Fetal umbilical velocimetry using continuous-wave and pulsed-wave Doppler ultrasound in high-risk pregnancies: a comparison of systolic to diastolic ratios Obstet Gynecol 72 1988 607 610
29. J.R. Green Placenta previa and abruption placentae R.K. Creasy, R. Resnik, Maternal-fetal medicine 3rd ed. 1994 WB Saunders Philadelphia [PA] 602 619
30. K. Shimada, K. Murakami, M. Shozu, T. Segawa, H. Sumitani, and M. Inoue Sex-determining region Y levels in maternal plasma: evaluation in abnormal pregnancy J Obstet Gynaecol Res 30 2004 148 154
31. I. Hromadnikova, L. Zejskova, K. Kotlabova, T. Jancuskova, J. Doucha, and R. Vlk Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences-evaluation of diagnostic possibilities for predicting placental insufficiency DNA Cell Biol 29 2010 295 301